cholecalciferol
AssetSupplementAlso Test group, Cholecalciferol (Vitamin D3), MK0217A, Vitamin D3
Vitamin D receptor agonist regulating calcium absorption and bone mineralization.
- Stage
- Phase 3
- Modality
- Supplement
- Target
- VDR
- Indications
- 6
- Trials
- 352
- Developers
- 4
Indications
6Osteoporosis
Phase 3COMPLETEDNCT00692913clinicaltrials.gov7 Oct 2026
Osteoporosis postmenopausal
Phase 3COMPLETEDNCT00729651clinicaltrials.gov7 Oct 2026
Postmenopausal osteoporosis
Phase 3TERMINATEDNCT00529373clinicaltrials.gov7 Oct 2026
3 more
- Targets and what it contains1
- Owner and partners4
- Trials352
- Evidence for its targets2
- Competitors1
- Aging relevance1
- Signals8
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 14 sources